GRK2 Inhibition in Heart Failure: Something Old, Something New

By  

Current Pharmaceutical Design, Vol. 18, Iss. 2, 2012-01 ,pp. : 186-191

Bentham Science Publishers

Access to resources Recommend Favorite

2 -Adrenergic control of dopamine overflow and metabolism in mouse striatum

By Yavich L.   Lappalainen R.   Sirvio J.   Haapalinna A.   MacDonald E.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 113-119

Elsevier

Access to resources Recommend Favorite

Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects

By Monkkonen H.   Tormalehto S.   Asunmaa K.   Niemi R.   Auriola S.   Vepsalainen J.   Monkkonen J.  

European Journal of Pharmaceutical Sciences, Vol. 19, Iss. 1, 2003-05 ,pp. : 23-29

Elsevier

Access to resources Recommend Favorite

GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting

By  

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 317-326

Bentham Science Publishers

Access to resources Recommend Favorite

Thiols in Cellular Redox Signalling and Control

By  

Current Medicinal Chemistry, Vol. 8, Iss. 7, 2001-06 ,pp. : 763-772

Bentham Science Publishers

Access to resources Recommend Favorite